CAD & Atherosclerosis
Conference Coverage
IRONMAN galvanizes case for IV iron repletion in heart failure
The trial missed its primary endpoint, but makes unique contributions; many see it as further evidence that the treatment helps iron-deficient...
Feature
Medical school culinary medicine programs grow despite limited funding
As part of Dr. Marvasti’s program, students learn cooking fundamentals through chef demonstrations and hands-on practice – to teach students how...
Conference Coverage
Statins boost glycemia slightly, but CVD benefits prevail
Meta-analysis of 23 trials confirmed statins raise glycemia and can trigger diabetes, but the effect pales compared with their CVD prevention.
Conference Coverage
Dietary supplements hyped as LDL cholesterol lowering are a bust: SPORT
The list of supplements without effects on LDL in the placebo-controlled trial include commercial preparations of fish oil, cinnamon, garlic,...
Conference Coverage
New trial suggests CV benefit with EPA: RESPECT-EPA
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose...
Conference Coverage
Precision CAD testing shows 70% cut in composite risk at 1 year
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
Conference Coverage
ISCHEMIA-EXTEND: Conservative stable CAD management holds up
The ISCHEMIA trial results showed equipoise between conservative and invasive management of stable CAD. Extended follow-up strengthened the...
Conference Coverage
Moving the needle: SGLT2 inhibitor role for isolated kidney disease
When the EMPA-Kidney study began – before results from DAPA-CKD were known – “we never imagined such a large effect” on important endpoints in...
Conference Coverage
In CABG, radial artery works best for second key graft: RAPCO at 15 years
With more than 15 years of follow-up, the radial artery beats other options for the second key coronary target in coronary artery bypass surgery...
Conference Coverage
Diuretic agents equal to prevent CV events in hypertension: DCP
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...